Special Issue "Molecular Features of Lysosomal Storage Disorders"
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (20 September 2018)
Prof. Dr. Ritva Tikkanen
This Special Issue is a continuation of our 2016 Special Issue, “Lysosomal Storage Disorders: Novel Concepts, Therapeutic Aspects and Beyond”.
Lysosomal storage disorders (LSDs) are a heterogeneous group of rare monogenic diseases that are characterized by aberrant lysosomes with storage material. These diseases frequently manifest as severe defects of the central nervous system, mental retardation and reduced life span. Most LSDs result from a deficiency of a single enzyme, whereas others are caused by mutations in non-enzymatic proteins. In the past couple of years, our knowledge about the pathogenesis and the molecular details of the genes involved has substantially increased. These findings have forced us to rethink some old central dogmas about these diseases and revealed novel aspects about the pathomechanisms. Importantly, novel therapy options have become available, or are under development, for some LSDs that were previously considered fatal.
The purpose of this Special Issue is to summarize our current understanding about the molecular features of LSDs and the involvement of various cellular pathways, such as autophagy, neuroinflammation, microgliosis and signaling in their pathogenesis. We also highly welcome papers addressing the molecular aspects of current and prospective therapies for LSDs, as well as novel concepts and hypothesis about these disorders, including their connections to more common diseases, such as Alzheimer or Parkinson. However, papers addressing disease phenotypes or clinical studies without a clear molecular emphasis are not within the scope of this issue. We encourage the submission of review articles and original research papers. Our aim is to provide a comprehensive update on LSDs, their pathomechanisms and therapy options at the molecular level.Prof. Dr. Ritva Tikkanen
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- lysosomal storage disorders
- enzyme replacement
- gene therapy
- substrate reduction
- pharmacological chaperones